NCT01068626View on ClinicalTrials.gov

Rosuvastatin in Visceral Adiposity

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Abdominal Obesity
Interventions
DRUG

Rosuvastatin

10 mg once daily

DRUG

Placebo for rosuvastatin

once daily

Trial Locations (1)

413 45

Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothernburg, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

Göteborg University

OTHER

NCT01068626 - Rosuvastatin in Visceral Adiposity | Biotech Hunter | Biotech Hunter